28
Participants
Start Date
May 1, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Controlled CO2 delivery
The use of a controlled CO2 delivery offers a straightforward way to increase arterial CO2. Controlled CO2 inhalation may offer a novel hemodynamic therapy for patients with Neurogenic Orthostatic Hypotension
Controlled CO2 delivery (Sham)
For this intervention, we will be using this device set at 0% CO2 for our sham comparison.
University of Calgary, Calgary
University of Calgary
OTHER